Malassezia pachydermatis Acquires Resistance to Polyenes in the Laboratory Model
Pathogens · 2025
DOI: 10.3390/pathogens14111162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Urszula Czyżewska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Biotechnology, Faculty of Biology, University of Bialystok, K. Ciolkowskiego 1J, 15-245 Bialystok, Poland. Hauptthemen laut MEDLINE: Malassezia, Antifungal Agents, Drug Resistance, Fungal, Natamycin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre.
Abstract (Originalsprache)
This study presents a model investigation into the development of tolerance to polyene antifungal drugs (nystatin and natamycin) in strains of Malassezia pachydermatis. This species, commonly associated with external ear canal infections in dogs, has emerged as increasingly significant in the broader context of growing fungal resistance to treatment. In the experiment, 10 strains of M. pachydermatis were passaged over a period of 105 weeks on media containing sublethal concentrations of nystatin and natamycin. Minimal inhibitory (MIC) and minimal fungicidal concentration (MFC) values were regularly assessed to monitor tolerance development. The results revealed a varied response among the strains: Some were eliminated during the process, while others showed a gradual increase in MIC values, up to fivefold in the case of nystatin. In several strains, acquired resistance remained stable even after passaging in drug-free conditions, whereas others reverted to their original susceptibility. The model demonstrated that resistance does not emerge immediately; significant changes appeared only after 30–45 passages. The authors propose this model as a valuable tool for tracking sequential changes that lead to resistance development. Such an approach may support targeted therapy development and help identify strains predisposed to drug adaptation. These findings hold promise for assessing therapeutic risk in immunosuppressed patients and for building resistance datasets that can support artificial intelligence algorithms in predicting fungal resistance mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Biotechnology, Faculty of Biology, University of Bialystok, K. Ciolkowskiego 1J, 15-245 Bialystok, Poland.
- Doctoral School, University of Bialystok, K. Ciolkowskiego 1K, 15-245 Bialystok, Poland.
- Metabolomics and Proteomics Laboratory, Clinical Research Centre, Medical University of Bialystok, Sklodowskiej 24a, 15-276 Bialystok, Poland.
ORCID-Profile: Urszula Czyżewska, Sandra Chmielewska, Marek Bartoszewicz, Adam Tylicki
Förderung
- National Science Centre
Zitieren
APA
Czyżewska, U., Chmielewska, S., Bartoszewicz, M., & Tylicki, A. (2025). Malassezia pachydermatis Acquires Resistance to Polyenes in the Laboratory Model. Pathogens. https://doi.org/10.3390/pathogens14111162
Vancouver
Czyżewska U, Chmielewska S, Bartoszewicz M, Tylicki A. Malassezia pachydermatis Acquires Resistance to Polyenes in the Laboratory Model. Pathogens. 2025. doi:10.3390/pathogens14111162
BibTeX
@article{Czyewska2025,
author = {Czyżewska, Urszula and Chmielewska, Sandra and Bartoszewicz, Marek and Tylicki, Adam},
title = {Malassezia pachydermatis Acquires Resistance to Polyenes in the Laboratory Model},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14111162}
}
EUVIMED